Ten years after the international committee of medical journal editors' clinical trial registration initiative, one quarter of phase 3 pediatric epilepsy clinical trials still remain unpublished: A cross sectional analysis

PLoS ONE

Volumn 11, Issue 1, 2016, Pages

  Lampert, Anette ^a   Hoffmann, Georg F ^b   Ries, Markus ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; BRIVARACETAM; CARBAMAZEPINE; CARISBAMATE; CLOBAZAM; DIAZEPAM; ESLICARBAZEPINE; ETIRACETAM; FOSPHENYTOIN SODIUM; GABAPENTIN; HARKOSERIDE; LAMOTRIGINE; LORAZEPAM; MELATONIN; MIDAZOLAM; OXCARBAZEPINE; PARALDEHYDE; PERAMPANEL; PHENYTOIN; PREDNISOLONE; PREGABALIN; PROGESTERONE; RUFINAMIDE; TOPIRAMATE; VALPROIC ACID; ZONISAMIDE;

ADOLESCENT; ARTICLE; CHILD; CHILD HEALTH CARE; CROSS-SECTIONAL STUDY; DIET THERAPY; EDITOR; EPILEPSY; EVIDENCE BASED MEDICINE; HUMAN; MODIFIED ATKIN DIET; OUTCOME ASSESSMENT; PHASE 3 CLINICAL TRIAL (TOPIC); PUBLICATION; PUBLISHING; REGISTRATION; CLINICAL TRIAL (TOPIC); FACTUAL DATABASE; REGISTER;

ADOLESCENT; CHILD; CLINICAL TRIALS AS TOPIC; CROSS-SECTIONAL STUDIES; DATABASES, FACTUAL; EPILEPSY; HUMANS; PUBLICATION BIAS; REGISTRIES;

EID: 84954044714     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0144973     Document Type: Article

References (33)

1. Song F, Parekh S, Hooper L, Loke YK, Ryder J, Sutton AJ, et al. Dissemination and publication of research findings: an updated review of related biases. Health technology assessment. 2010;14(8):iii, ix-xi, 1-193. doi: 10.3310/hta14080 PMID: 20181324.
2. Ross JS, Mulvey GK, Hines EM, Nissen SE, Krumholz HM. Trial publication after registration in Clinical-Trials. Gov: a cross-sectional analysis. PLoS medicine. 2009;6(9):e1000144. doi: 10.1371/journal. pmed.1000144 PMID: 19901971; PubMed Central PMCID: PMC2728480.
3. Jones CW, Handler L, Crowell KE, Keil LG, Weaver MA, Platts-Mills TF. Non-publication of large randomized clinical trials: cross sectional analysis. Bmj. 2013;347:f6104. doi: 10.1136/bmj.f6104 PMID: 24169943; PubMed Central PMCID: PMC3812466.
4. Ross JS, Tse T, Zarin DA, Xu H, Zhou L, Krumholz HM. Publication of NIH funded trials registered in ClinicalTrials.gov: cross sectional analysis. Bmj. 2012;344:d7292. doi: 10.1136/bmj.d7292 PMID: 22214755; PubMed Central PMCID: PMC3623605.
5. Bourgeois FT, Murthy S, Mandl KD. Outcome reporting among drug trials registered in ClinicalTrials. gov. Annals of internal medicine. 2010;153(3):158-66. doi: 10.7326/0003-4819-153-3-201008030-00006 PMID: 20679560; PubMed Central PMCID: PMC3374868.
6. Nevalainen O, Ansakorpi H, Simola M, Raitanen J, Isojarvi J, Artama M, et al. Epilepsy-related clinical characteristics and mortality: a systematic review and meta-analysis. Neurology. 2014;83(21):1968-77. Epub 2014/10/24. doi: 10.1212/wnl.0000000000001005 PMID: 25339211.
7. Berg AT, Baca CB, Loddenkemper T, Vickrey BG, Dlugos D. Priorities in pediatric epilepsy research: improving children's futures today. Neurology 2013;81:1166-75. doi: 10.1212/WNL. 0b013e3182a55fb9 PMID: 23966254
8. French JA. Refractory epilepsy: clinical overview. Epilepsia. 2007;48 Suppl 1:3-7. doi: 10.1111/j.1528-1167.2007.00992.x PMID: 17316406.
9. Potschka H, Brodie MJ. Pharmacoresistance. Handbook of clinical neurology. 2012;108:741-57. Epub 2012/09/04. doi: 10.1016/b978-0-444-52899-5.00025-3 PMID: 22939063.
10. Marson AG, Kadir ZA, Hutton JL, Chadwick DW. The new antiepileptic drugs: a systematic review of their efficacy and tolerability. Epilepsia. 1997;38(8):859-80. PMID: 9579887.
11. Greenwood RS. Adverse effects of antiepileptic drugs. Epilepsia. 2000;41 Suppl 2:S42-52. PMID: 10885739.
12. Cramer J, Vachon L, Desforges C, Sussman NM. Dose frequency and dose interval compliance with multiple antiepileptic medications during a controlled clinical trial. Epilepsia. 1995;36(11):1111-7. PMID: 7588455.
13. EMA. Assessment of the paediatric needs epilepsy 2006 [cited 2015 15 Apr]. Available from: http://www.ema.europa.eu/docs/en-GB/document-library/Other/2009/10/WC500004047.pdf
14. Glauser T, Ben-Menachem E, Bourgeois B, Cnaan A, Chadwick D, Guerreiro C, Kalviainen R, Mattson R, Perucca E, Tomson T. ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia 2006;47:1094-120. PMID: 16886973
15. Rising K, Bacchetti P, Bero L. Reporting bias in drug trials submitted to the Food and Drug Administration: review of publication and presentation. PLoS medicine. 2008;5(11):e217; discussion e. doi: 10. 1371/journal.pmed.0050217 PMID: 19067477; PubMed Central PMCID: PMC2586350.
16. Melander H, Ahlqvist-Rastad J, Meijer G, Beermann B. Evidence b (i) ased medicine-selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applications. Bmj. 2003;326(7400):1171-3. doi: 10.1136/bmj.326.7400.1171 PMID: 12775615; PubMed Central PMCID: PMC156459.
17. Hart B, Lundh A, Bero L. Effect of reporting bias on meta-analyses of drug trials: reanalysis of metaanalyses. Bmj. 2012;344:d7202. doi: 10.1136/bmj.d7202 PMID: 22214754.
18. Whittington CJ, Kendall T, Fonagy P, Cottrell D, Cotgrove A, Boddington E. Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data. Lancet. 2004;363(9418):1341-5. doi: 10.1016/S0140-6736 (04) 16043-1 PMID: 15110490.
19. Turner EH, Matthews AM, Linardatos E, Tell RA, Rosenthal R. Selective publication of antidepressant trials and its influence on apparent efficacy. The New England journal of medicine. 2008;358(3):252-60. doi: 10.1056/NEJMsa065779 PMID: 18199864.
20. Nissen SE, Wolski K. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. The New England journal of medicine. 2007;356(24):2457-71. doi: 10.1056/NEJMoa072761 PMID: 17517853.
21. Cowley AJ, Skene A, Stainer K, Hampton JR. The effect of lorcainide on arrhythmias and survival in patients with acute myocardial infarction: an example of publication bias. International journal of cardiology. 1993;40(2):161-6. PMID: 8349379.
22. Echt DS, Liebson PR, Mitchell LB, Peters RW, Obias-Manno D, Barker AH, et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. The New England journal of medicine. 1991;324(12):781-8. doi: 10.1056/NEJM199103213241201 PMID: 1900101.
23. Pearn J. Publication: an ethical imperative. Bmj. 1995;310(6990):1313-5. PMID: 7773049; PubMed Central PMCID: PMC2549684.
24. Munro AJ. Publishing the findings of clinical research. Bmj. 1993;307(6915):1340-1. PMID: 8257891; PubMed Central PMCID: PMC1679429.
25. Guyatt GH, Haynes RB, Jaeschke RZ, Cook DJ, Green L, Naylor CD, et al. Users' Guides to the Medical Literature: XXV. Evidence-based medicine: principles for applying the Users' Guides to patient care. Evidence-Based Medicine Working Group. Jama. 2000;284(10):1290-6. PMID: 10979117.
26. FDAAA. Sec. 801. Expanded clinical trial registry data bank 2007 [cited 2015 21 Apr]. Available from: http://www.gpo.gov/fdsys/pkg/PLAW-110publ85/html/PLAW-110publ85.htm.
27. De Angelis C, Drazen JM, Frizelle FA, Haug C, Hoey J, Horton R, et al. Clinical trial registration: a statement from the International Committee of Medical Journal Editors. The New England journal of medicine. 2004;351(12):1250-1. doi: 10.1056/NEJMe048225 PMID: 15356289.
28. Schulz KF, Altman DG, Moher D, Group C. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. PLoS medicine. 2010;7(3):e1000251. doi: 10.1371/journal.pmed. 1000251 PMID: 20352064; PubMed Central PMCID: PMC2844794.
29. Mathieu S, Boutron I, Moher D, Altman DG, Ravaud P. Comparison of registered and published primary outcomes in randomized controlled trials. Jama. 2009;302(9):977-84. doi: 10.1001/jama.2009.1242 PMID: 19724045.
30. Prayle AP, Hurley MN, Smyth AR. Compliance with mandatory reporting of clinical trial results on ClinicalTrials. gov: cross sectional study. Bmj. 2012;344:d7373. doi: 10.1136/bmj.d7373 PMID: 22214756.
31. Tishler CL, Reiss NS. Pediatric drug-trial recruitment: enticement without coercion. Pediatrics 2011;127:949-54. doi: 10.1542/peds.2010-2585 PMID: 21464193
32. ICMJE. Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals 2014 [cited 2015 21 Apr]. Available from: http://icmje.org/icmje-recommendations.pdf
33. Anderson ML, Chiswell K, Peterson ED, Tasneem A, Topping J, Califf RM. Compliance with results reporting at ClinicalTrials.gov. The New England journal of medicine. 2015;372(11):1031-9. doi: 10. 1056/NEJMsa1409364 PMID: 25760355.